Answers are grounded in this paper and cite their sources.
Highlights the clinical utility of ST-T segment morphology and symptom triggers in predicting the specific genetic mutation in patients with congenital long QT syndrome.
See article by Huang et al. [14] (pages 670–680) in this issue. The electrophysiological basis of the congenital long QT syndrome (LQTS), including both the Romano–Ward (RW) and the Jervell and Lange–Nielsen syndrome (JLN), relates to dysfunctioning ion channels, secondary to genetic aberrancies in their encoding genes (for review see Roden and Spooner [1]). Because these ion channels have different time and voltage characteristics gene-specific elements in clinical presentation have been searched for. Indeed, a gene-differentiating potential has been demonstrated, initially in small series and later confirmed in larger patient populations, for the morphology of ST-T segments [2–4] and for symptoms-related triggers [5–7]. To some extent also the clinical course including prognosis relies on the underlying gene defect [8]. Based on these data and other, more subtle differences [9], correct prediction of the genotype of clinically affected patients is feasible with reasonable accuracy. At present this prediction only refers to the causally related gene, i.e. KCNQ1, KCNH2 (HERG) or SCN5A and not to the site of a mutation within a specific gene. Recent data suggest, however, that, for example in LQT2/KCNH2 specific ST-T segment characteristics exist for the type and localization of mutations [4].
No takes yet. Share an insight, caveat, or question.
Arthur A.M. Wilde (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: